Mylan rumored to have made second Meda bid

Specialty pharma company Meda AB (SSE:MEDAA) gained SEK12 (10%) to SEK128.50 on Friday on media reports that generics company Mylan Inc. (NASDAQ:MYL) made another bid to acquire Meda. Earlier this month, Meda's board rejected a proposal from Mylan "to combine the two businesses." According to reports, Mylan upped its offer to SEK145 from SEK130 per share. The SEK145 price would value Meda at SEK43.8 billion ($6.6 billion) based on 302.2 million shares outstanding. The companies declined to comment. ...